Biotech Akari Therapeutics to Participate in Two January Virtual Investor Conferences January 6, 2021
Biotech Atossa Therapeutics Announces Pricing of $25.2 Million Registered Direct Offering Priced At-The-Market January 6, 2021
Biotech Citius Pharmaceuticals to Present Update on Proprietary Product Candidates at Two Virtual Conferences in January January 6, 2021
Biotech Checkpoint Therapeutics to Participate in Three January 2021 Virtual Investor Conferences January 6, 2021
Biotech Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in January 2021 January 6, 2021